Trupanion (NASDAQ:TRUP) Sets New 52-Week High – Here’s Why

Trupanion, Inc. (NASDAQ:TRUP) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $54.15 and last traded at $53.76, with a volume of 15921 shares trading hands. The stock had previously closed at $53.50.

Analyst Upgrades and Downgrades

Several research firms have recently commented on TRUP. Bank of America upped their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler increased their price objective on Trupanion from $38.00 to $45.00 and gave the stock a “neutral” rating in a report on Wednesday, October 2nd. William Blair began coverage on Trupanion in a research note on Friday, July 19th. They set an “outperform” rating on the stock. Finally, Stifel Nicolaus increased their price target on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion has a consensus rating of “Moderate Buy” and a consensus target price of $41.83.

Trupanion Trading Down 1.2 %

The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The business has a 50 day simple moving average of $44.93 and a 200-day simple moving average of $34.23. The stock has a market capitalization of $2.31 billion, a P/E ratio of -121.86 and a beta of 1.73.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.04. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The firm had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $309.33 million. During the same period in the previous year, the business earned ($0.33) earnings per share. Trupanion’s revenue for the quarter was up 16.3% compared to the same quarter last year. On average, analysts predict that Trupanion, Inc. will post -0.34 EPS for the current year.

Insider Buying and Selling

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,764 shares of company stock worth $405,238 in the last ninety days. 5.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Trupanion

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. ProShare Advisors LLC boosted its position in shares of Trupanion by 33.8% in the first quarter. ProShare Advisors LLC now owns 121,417 shares of the financial services provider’s stock worth $3,352,000 after buying an additional 30,645 shares during the period. Susquehanna Fundamental Investments LLC purchased a new position in Trupanion during the 1st quarter valued at about $473,000. Renaissance Technologies LLC purchased a new position in Trupanion during the 2nd quarter valued at about $4,739,000. Marshall Wace LLP increased its holdings in shares of Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after purchasing an additional 116,496 shares during the period. Finally, Wellington Management Group LLP lifted its position in shares of Trupanion by 34.6% in the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock worth $74,862,000 after purchasing an additional 630,155 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.